MEDIA ALERT: Element Biosciences to Unveil its AVITI™ System at “Sequencing Reimagined” Virtual Event on March 14, 2022

SAN DIEGO--(BUSINESS WIRE)-- Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, is hosting a virtual event to launch its AVITI benchtop sequencer that offers unprecedented performance, cost and flexibility. The virtual event will occur on March 14 at 9 a.m. PT/5 p.m. CET and will highlight AVITI’s product specs, data quality, and pricing information.

Early AVITI adopters, key executives from Element Biosciences, J.P. Morgan Chase & Co. and industry-leading partner companies are slated to speak at the 3-hour event. Topics will include early adopter and industry-leader experiences with AVITI, and application notes and testimonials from NGS workflow partners including library prep and data analysis. Companies like DeepVariant, Fabric Genomics, Jumpcode Genomics and Sentieon will share their firsthand experiences with the data generated from AVITI. Element will also share data from the integration of recently acquired Loop Genomics’ long-read technology with AVITI’s short read sequencing.

View the full agenda and register to attend the virtual event: https://registration.elementbiosciences.com/

About Element Biosciences, Inc.

Element Biosciences is a multi-disciplinary life science company currently focused on developing disruptive DNA sequencing technology for research and diagnostic markets. Through innovating every fundamental element of a sequencing system, Element will empower customers with affordable high-quality data and an improved user experience, which in turn will accelerate scientific discoveries and broaden the use of genomic medicine. To learn more about Element, please visit www.elementbiosciences.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20220307005093/en/